11/18
08:50 am
ymab
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $23.00 price target on the stock.
Medium
Report
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $23.00 price target on the stock.
11/18
08:47 am
ymab
Rating for YMAB
Medium
Report
Rating for YMAB
11/18
08:47 am
ymab
Rating for YMAB
Medium
Report
Rating for YMAB
11/15
03:26 pm
ymab
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Low
Report
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
9/10
09:12 am
ymab
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $23.00 price target on the stock.
Low
Report
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $23.00 price target on the stock.
9/10
09:12 am
ymab
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $23.00 price target on the stock.
Low
Report
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $23.00 price target on the stock.
9/10
08:59 am
ymab
Rating for YMAB
Low
Report
Rating for YMAB
9/10
08:59 am
ymab
Rating for YMAB
Low
Report
Rating for YMAB
9/9
01:03 pm
ymab
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock.
Low
Report
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock.
9/9
12:17 pm
ymab
Rating for YMAB
Medium
Report
Rating for YMAB